Prostate cancer: Biological dose considerations and constraints in tele- and brachytherapy

Strahlentherapie und Onkologie

Volumn 183, Issue SUPPL. 2, 2007, Pages 14-15

  Dörr, Wolfgang ^a   Jaal, Jana ^a,b   Zips, Daniel ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Brachytherapy; Prostate; Radiation side effects; Teletherapy; Tumor; Volume effects

Indexed keywords

ATROPHY; BLADDER; BLOOD VESSEL WALL; BRACHYTHERAPY; CANCER STAGING; CONFERENCE PAPER; DEPLETION; DISEASE FREE SURVIVAL; EDEMA; EPITHELIAL CELL DEPLETION; EXPERIMENTAL STUDY; HYALINE DEGENERATION; MUCOSA; PATHOGENESIS; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RECTUM; RISK FACTOR; SUBMUCOSA; TREATMENT DURATION; TREATMENT RESPONSE; VASCULAR FIBROSIS;

BRACHYTHERAPY; DOSE FRACTIONATION; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTUM; RISK FACTORS; TIME FACTORS; URINARY BLADDER;

EID: 37549019260     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-2006-5     Document Type: Conference Paper

References (19)

1. Bentzen SM, Ritter MA. The alpha/beta ratio for prostate cancer: what is it, really? Radiother Oncol 2005;76:1-3.
2. Boehmer D, Kuczer D, Badakhshi H, Stiefel S, Kuschke W, Wernecke KD, Budach V. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy. Strahlenther Onkol 2006;182:277-82.
3. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999;43:1095-101.
4. Dobler B, Mai S, Ross C, Wolff D, Wertz H, Lohr F, Wenz F. Evaluation of possible prostate displacement induced by pressure applied during transabdominal ultrasound image acquisition. Strahlenther Onkol 2006;182:240-6.
5. Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001:61:223-31.
6. Dörr W, Satthoff I. Einfluß der Gesamtbehandlungszeit auf Strahlenfolgen an der Harnblase - tierexperimentelle Daten. Strahlenther Onkol 1996;172, Sonderheft I:42.
7. Dubray BM, Thames HD. Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume. Radiother Oncol 1994;33:41-7.
8. Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 2005;44:265-76.
9. Guckenberger M, Flentje M. Intensity-Modulated Radiotherapy (IMRT) of Localized Prostate Cancer: A Review and Future Perspectives. Strahlenther Onkol 2007;183:57-62.
10. Guckenberger M, Pohl F, Baier K, Meyer J, Koelbl O, Flentje M, Vordermark D. Influence of Rectum Delineation (Rectal Volume vs. Rectal Wall) on IMRT Treatment Planning of the Prostate. Strahlenther Onkol 2006;182:721-726.
11. Hille A, Tows N, Schmidberger H, Hess CF. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio. Strahlenther Onkol 2005;181:789-95.
12. Jaal J, Dörr W. Radiation-induced damage to mouse urothelial barrier. Radiother Oncol 2006;80:250-6.
13. Jaal J, Dörr W. Radiation induced late damage to the barrier function of small blood vessels in mouse bladder. J Urol 2006;176:2696-700.
14. Kummermehr J, Trott KR. Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume. Radiother Oncol 1994;33:91-2.
15. Pinkawa M, Siluschek J, Gagel B, Piroth MD, Demirel C, Asadpour B, Eble MJ. Postoperative radiotherapy for prostate cancer: evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy). Strahlenther Onkol 2007;183:23-9.
16. Thames HD, D'Souza W, Kuban DA. Dual radiobiological interpretations of retrospective clinical data: the time factor. Int J Radiat Biol 2003;79:503-9.
17. Valdagni R, Italia C, Montanaro P, Lanceni A, Lattuada P, Magnani T, Fiorino C, Nahum A. Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy. Radiother Oncol. 2005;75:74-82.
18. Wertz H, Lohr F, Dobler B, Mai S, Wenz F. Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate. Strahlenther Onkol 2007;183:203-10.
19. Zimmermann F, Molls M. Prostata. In:Bamberg M, Molls M, Sack H (Eds). Radioonkologie Band 2 Klinik, München: W. Zuckschwerdt Verlag, 2004; 692-719.